Behavioural versus Pharmacological Interventions to Treat Anxiety and Depression – When to Prescribe What?


Presentation Description:
This presentation will describe clinical approaches to the assessment and treatment of anxiety and depression in youth with cancer. Using case examples, we will review the range of symptoms that may present, and describe behavioural as well as pharmacologic approaches to treatment.

Anna C Muriel, MD, MPH
Division Chief, Paediatric Psychosocial Oncology, Dana Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, MA

Dr. Anna (Nina) Muriel is a child psychiatrist and Chief of the Division of Pediatric Psychosocial Oncology at the Dana-Farber Cancer Institute. She is a graduate of Brown University and Tufts University School of Medicine, and trained at Massachusetts General and McLean Hospitals in Boston. Her clinical and academic interests include the impact of cancer on children and families, the delivery of mental health services, and the use of psychiatric medications in pediatric oncology. She is Assistant Professor of Psychiatry at Harvard Medical School, co-author of the book “Raising an Emotionally Healthy Child When a Parent is Sick,” and co-editor of “Pediatric Psychosocial Oncology: Textbook for Multidisciplinary Care.”

Comments are closed.